Tag: Quality

Congressional hearing exposes US organ transplant system failures

Editor's Note Lost organs, widespread fraud, and live donors mistakenly presumed deceased are among the alarming issues with the US organ transplant system detailed in a recent Congressional hearing, MedPage Today reported September 11. As part of the House Energy & Commerce Oversight and Investigations Subcommittee, the hearing aimed to…

Read More

By: Matt Danford
September 12, 2024
Share

Trump-Harris debate highlights contrast on abortion, Affordable Care Act

Editor's Note The healthcare portion of the September 10 debate between former President Donald Trump and Vice President Kamala Harris focused on two issues: abortion and the Affordable Care Act (ACA).  Becker’s Hospital Review published key takeaways from the exchange September 11. According to the article, Trump reiterated that the…

Read More

By: Matt Danford
September 11, 2024
Share

Study: bariatric surgery beats medication for hypertension control

Editor's Note Findings to be presented at the American Heart Association's Hypertension Scientific Sessions 2024 suggest bariatric surgery may offer more effective long-term control of high blood pressure for people with obesity compared to medications and lifestyle changes, according to a September 5 report in News Medical. According to the…

Read More

By: Matt Danford
September 6, 2024
Share

Flexibility for clinicians in managing RAS inhibitors in noncardiac surgery

Editor's Note A new study, the Stop-or-Not Trial, has found no significant difference in outcomes for patients undergoing noncardiac surgery who either continued or discontinued their renin-angiotensin system (RAS) inhibitor therapy, MedPage Today August 31 reports. The randomized clinical trial, which included over 2,200 patients, reported the rate of death…

Read More

By: Tarsilla Moura
September 3, 2024
Share

Anesthesia workforce challenges taking center stage

Every year, OR Manager shines a light on staffing issues via the Salary/Career Survey. In this issue, two articles take a careful look at the career and profile of the perioperative leader in both inpatient and outpatient settings. Next month, two more articles will do the same with salary trends…

Read More

By: Tarsilla Moura
August 28, 2024
Share

Offsite sterilization fuels onsite efficiency for lean ASCs

For many in the healthcare industry, imagining surgery without onsite sterile processing seems unthinkable. Then again, performing total joints in an ambulatory surgery center (ASC) was unthinkable 10 years ago. ASC sterile processing departments (SPDs) are generally not designed to handle the high volumes of instrument trays, vendor trays, and…

Read More

By: Lacey Dyer, RN, BSN, CASC
August 28, 2024
Share

Water quality: 5 Ws and an H for sterile processing pros

Asking who, what, why, when, where, and how—otherwise known as the “5 Ws and an H”— is a time-tested way for writers and researchers to ensure comprehensive coverage of any topic. Here, we apply this framework from the perspective of sterile processing department (SPD) professionals seeking to start a water…

Read More

By: Angela Lewellyn, LPN, CRCST, CER, CHL
August 28, 2024
Share

Pilot project takeoff proves promise of AI staff optimization

Perioperative leaders face mounting pressures to optimize resources, reduce costs, and improve patient outcomes. However, one challenge stands out among the rest: OR staffing shortages. According to a November/December survey conducted by LeanTaaS in collaboration with OR Manager, staff recruitment and retention is a top priority for OR leaders this…

Read More

By: Stacey Leadbeater
August 28, 2024
Share

Studies highlight success strategies for combatting handoff communication failure, care inequity

Editor's Note Recent research sheds new light on addressing two of the most pressing problems for surgical care: handoff communication failures and care bias and inequities leading to adverse—and preventable—events.   These problems are the subjects of two separate success stories in the August issue of The Joint Commission Journal…

Read More

By: Matt Danford
August 23, 2024
Share

Immunotherapy’s FDA approval expected to improve lung cancer treatment

Editor's Note The US Food & Drug Administration (FDA) has approved immunotherapy durvalumab for perioperative treatment of resectable non-small cell lung cancer (NSCLC), according to an August 15 announcement. The approval is for durvalumab (Imfinzi, AstraZeneca) in combination with platinum-based chemotherapy as a neoadjuvant treatment, followed by durvalumab alone as…

Read More

By: Matt Danford
August 22, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat